Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Elucidating cancer cachexia–mediated aberrant cardiac wasting signaling in human iPSC-derived cardiac muscle
Nora Hosny, Houda Cohen, Mohamed Waleed Elafany, Jeff Schreifels, John Bauer, Rishi Gulati, Brian R. Thompson, Julia C. Liu, Joseph M. Metzger
Nora Hosny, Houda Cohen, Mohamed Waleed Elafany, Jeff Schreifels, John Bauer, Rishi Gulati, Brian R. Thompson, Julia C. Liu, Joseph M. Metzger
View: Text | PDF
Research Article Cardiology Oncology

Elucidating cancer cachexia–mediated aberrant cardiac wasting signaling in human iPSC-derived cardiac muscle

  • Text
  • PDF
Abstract

Cancer cachexia is a debilitating syndrome of involuntary body mass loss featuring profound skeletal muscle wasting and high mortality. Cardiac muscle wasting is prominent in cancer patients and cancer survivors. We developed a human induced pluripotent stem cell–derived cardiac myocyte (hiPSC-CM) platform modeling cancer cachexia using conditioned media and Transwell coculture with C26 or HCT116 tumor cells. Cachectic hiPSC-CMs exhibited atrophy, reduced contraction amplitude, prolonged relaxation time, and elevated oxygen consumption rate, reflecting wasting, contractile dysfunction, and metabolic dysregulation. Mechanistically, suppression of the AKT/mTORC1/S6 signaling axis notably reduced total and p-AKT, decreased the p-S6/S6 ratio, and downregulated RPTOR, which coincided with FOXO1/3 activation and FOXO1 nuclear translocation, promoting downstream atrophic remodeling. Concurrently, Atrogin-1 upregulation reduced calcineurin A, impairing NFAT nuclear translocation, thereby suppressing downstream growth signaling. Increased autophagic flux with an elevated LC3BII/LC3BI ratio accompanied these changes. Following withdrawal of cachexia-inducing stimuli, Atrogin-1 and autophagy markers normalized within 1 week; however, contractile and metabolic impairments persisted, indicating delayed functional recovery. These findings establish the FOXO/Atrogin-1/calcineurin A/NFAT axis, operating within the broader context of AKT/mTORC1 suppression, as a central regulatory mechanism of cachexia-induced cardiac wasting, unveiling a tractable therapeutic target.

Authors

Nora Hosny, Houda Cohen, Mohamed Waleed Elafany, Jeff Schreifels, John Bauer, Rishi Gulati, Brian R. Thompson, Julia C. Liu, Joseph M. Metzger

×

Figure 2

Cachectic hiPSC-CMs: morphological analysis and inflammatory response.

Options: View larger image (or click on image) Download as PowerPoint
Cachectic hiPSC-CMs: morphological analysis and inflammatory response.
(...
(A) Timeline of the experiment indicating cachexia phase. (B) Cell size reduction in cachectic hiPSCs-CM as shown in the representative immunofluorescence images stained with phalloidin and DAPI. Scale bar: 10 μm. (C) Summary of cell size reduction in cachectic hiPSC-CMs (n = 80–115/group). (D) Summary of nuclei number reduction in cachectic groups (supernatant and Transwell) in the 2 tested models (C26 or HCT116) (n = 6). (E) Representative images from control and cachectic hiPSCs-CMs showing cell death assessed using live/dead cell viability assay. Live cells were detected with calcein AM (green) dye and dead cells were detected using propidium iodide (red). Scale bar: 300 μm. (F) Summary of IL-6 protein expression in the media of cultured cells: C26 or HCT116 cells compared to hiPSC-CMs. (G) Violin plot of qPCR analysis of IL6 mRNA expression in C26 and HCT116 cells. (H) Heatmap of cytokine array measured in the collected media at the end of cachexia phase from C26-CM cachectic model. Data normalized using Z-score analysis (as explained in Methods). (I) Summary of qPCR analysis of IL6 mRNA expression in control and cachectic hiPSC-CMs (C26-CM cachectic model). Data are presented as mean ± SEM from 3 independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 by ANOVA (C and I) or paired t test (D).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts